about
A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and BeyondOptimizing outcomes in patients with chronic myeloid leukemia in chronic phase: comparative safety profiles of newer agents.Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Overcoming resistance in chronic myelogenous leukemia.
@en
Overcoming resistance in chronic myelogenous leukemia.
@nl
type
label
Overcoming resistance in chronic myelogenous leukemia.
@en
Overcoming resistance in chronic myelogenous leukemia.
@nl
prefLabel
Overcoming resistance in chronic myelogenous leukemia.
@en
Overcoming resistance in chronic myelogenous leukemia.
@nl
P2860
P1433
P1476
Overcoming resistance in chronic myelogenous leukemia.
@en
P2093
Francis J Giles
Susannah Cooper
P2860
P304
P356
10.3109/10428190903267559
P577
2009-11-01T00:00:00Z